Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shahzad Hassan, M.B.,B.S.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Shahzad Hassan's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Shahzad Hassan has written about over time.
Aged, 1 publications between 2024 and 2024, average publication date April 2024. Cardiovascular Diseases, 1 publications between 2024 and 2024, average publication date April 2024. Diabetes Mellitus, Type 2, 1 publications between 2024 and 2024, average publication date April 2024. Female, 1 publications between 2024 and 2024, average publication date April 2024. Guideline Adherence, 1 publications between 2024 and 2024, average publication date April 2024. Humans, 1 publications between 2024 and 2024, average publication date April 2024. Hypoglycemic Agents, 1 publications between 2024 and 2024, average publication date April 2024. Male, 1 publications between 2024 and 2024, average publication date April 2024. Middle Aged, 1 publications between 2024 and 2024, average publication date April 2024. Patient Education as Topic, 1 publications between 2024 and 2024, average publication date April 2024. Practice Guidelines as Topic, 1 publications between 2024 and 2024, average publication date April 2024. Telemedicine, 1 publications between 2024 and 2024, average publication date April 2024. Treatment Outcome, 1 publications between 2024 and 2024, average publication date April 2024.

To see the data from this visualization as text, click here.
Hassan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.